Stay updated with breaking news from Sara bonstein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Insmed Incorporated (NASDAQ:INSM – Get Free Report) saw unusually-high trading volume on Thursday after TD Cowen raised their price target on the stock from $45.00 to $67.00. TD Cowen currently has a buy rating on the stock. Approximately 2,243,974 shares changed hands during trading, an increase of 3% from the previous session’s volume of 2,186,428 […] ....
Bank of America reaffirmed their buy rating on shares of Insmed (NASDAQ:INSM – Free Report) in a research note issued to investors on Tuesday morning, Benzinga reports. Bank of America currently has a $40.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also weighed in on INSM. Barclays raised their […] ....
Insmed (NASDAQ:INSM – Get Free Report) had its price objective hoisted by equities research analysts at HC Wainwright from $52.00 to $70.00 in a report released on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s price objective would indicate a potential upside of 22.85% from the […] ....
Insmed (NASDAQ:INSM – Get Free Report) had its target price upped by analysts at Truist Financial from $48.00 to $68.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm presently has a “buy” rating on the biopharmaceutical company’s stock. Truist Financial’s price objective points to a potential upside of […] ....
Insmed (NASDAQ:INSM – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Truist Financial in a research note issued to investors on Thursday, Benzinga reports. They presently have a $48.00 price target on the biopharmaceutical company’s stock. Truist Financial’s price objective would suggest a potential upside of 92.38% from the stock’s […] ....